Sinopharm
1099.HK
$2.86
Share price
-1.11%
Change (1 day)
-15.93%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Sinopharm (1099.HK) - P/B ratio
P/B ratio as of May 2024 : 0.5239
According to Sinopharm's latest financial reports the company has a price-to-book ratio of 0.5239.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Sinopharm - P/B ratio (from 2009 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.4801 | -3.56% |
| 2022-12-31 | 0.4978 | 14.7% |
| 2021-12-31 | 0.4340 | -17.03% |
| 2020-12-31 | 0.5231 | -46.93% |
| 2019-12-31 | 0.9856 | -21.62% |
| 2018-12-31 | 1.26 | -6.38% |
| 2017-12-31 | 1.34 | -24.43% |
| 2016-12-31 | 1.78 | 0.98% |
| 2015-12-31 | 1.76 | 5.35% |
| 2014-12-31 | 1.67 | 7.2% |
| 2013-12-31 | 1.56 | -23.67% |
| 2012-12-31 | 2.04 | 14.85% |
| 2011-12-31 | 1.78 | -49.81% |
| 2010-12-31 | 3.54 | -9.61% |
| 2009-12-31 | 3.92 | |
| 2008-12-31 | N/A |